Brodt P, Feldman M, Segal S
Cancer Immunol Immunother. 1983;16(2):109-13. doi: 10.1007/BF00199241.
Normal syngeneic spleen cells were found to inhibit the local growth of the Lewis lung carcinoma (3LL) when injected together with the tumor cells at a ratio of 100:1 (spleen to tumor cells). The repeated injection of the tumor cells together with spleen cells eventually led to the selection of a tumor cell population whose growth could no longer be inhibited by normal spleen cells. In a previous report from this laboratory, a tumor subpopulation obtained in this manner was shown to display an increased metastatic potential, as well as a decreased sensitivity to natural resistance mechanisms in vivo and NK lysis in vitro. In the present study, we attempted to characterize the spleen cell population which mediated this selection process. We found that spleen cells depleted of T cells, B cells, or adherent macrophages retained their ability to inhibit tumor growth and select a resistant line in vivo. Subsequently, two tumor sublines derived by continuous in vivo passage of the parental tumor line with either unfractionated or nylon wool-non-adherent spleen cells were characterized. It was found that whereas both sublines were resistant to growth inhibition by normal spleen cells, only the subline derived from continuous passage with unfractionated spleen cells showed a reduction in the density of H-2b molecules expressed on the cell surface and an enhanced metastatic potency. These results suggest that the resistance of a tumor line to natural killer cells may not always result in an increase in its metastatic potential.
当正常同基因脾细胞与肿瘤细胞以100:1(脾细胞与肿瘤细胞)的比例共同注射时,发现其可抑制Lewis肺癌(3LL)的局部生长。肿瘤细胞与脾细胞反复共同注射最终导致选择出一个肿瘤细胞群体,其生长不再受正常脾细胞抑制。在本实验室之前的一份报告中,以这种方式获得的肿瘤亚群显示出转移潜能增加,以及对体内天然抗性机制和体外NK细胞裂解的敏感性降低。在本研究中,我们试图对介导这种选择过程的脾细胞群体进行表征。我们发现,去除T细胞、B细胞或黏附巨噬细胞的脾细胞仍保留其在体内抑制肿瘤生长和选择抗性细胞系的能力。随后,对通过亲代肿瘤系与未分离的或尼龙毛非黏附脾细胞在体内连续传代获得的两个肿瘤亚系进行了表征。结果发现,虽然两个亚系均对正常脾细胞的生长抑制具有抗性,但只有与未分离脾细胞连续传代获得的亚系在细胞表面表达的H-2b分子密度降低且转移能力增强。这些结果表明,肿瘤细胞系对自然杀伤细胞的抗性可能并不总是导致其转移潜能增加。